- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场单边下跌中，短期观望为宜，关注反弹时机
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有259家主力机构披露2025-06-30报告期持股数据，持仓量总计2.22亿股，占流通A股49.60%
- 波段诊断：
-
技术面诊股
诊断结果：5.4技术面打败了39%的股票
技术面评分前10的股票
近期的平均成本为44.14元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为44.14元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"44.14","date":1759137401,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.09.30","stock":"-0.74","trade":"1.51","ind":"0.52"},{"date":"2025.09.29","stock":"1.19","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"-0.18","trade":"-2.13","ind":"-0.65"},{"date":"2025.09.25","stock":"-1.19","trade":"0.08","ind":"-0.01"},{"date":"2025.09.24","stock":"0.66","trade":"1.51","ind":"0.83"},{"date":"2025.09.23","stock":"-2.67","trade":"-3.08","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.79","trade":"-0.10","ind":"0.22"},{"date":"2025.09.19","stock":"-0.07","trade":"-1.53","ind":"-0.30"},{"date":"2025.09.18","stock":"-1.61","trade":"-1.87","ind":"-1.15"},{"date":"2025.09.17","stock":"-1.15","trade":"-0.79","ind":"0.37"},{"date":"2025.09.16","stock":"-0.17","trade":"1.18","ind":"0.04"},{"date":"2025.09.15","stock":"-0.46","trade":"1.00","ind":"-0.26"},{"date":"2025.09.12","stock":"-0.88","trade":"1.42","ind":"-0.12"},{"date":"2025.09.11","stock":"1.64","trade":"-0.05","ind":"1.65"},{"date":"2025.09.10","stock":"-0.23","trade":"1.48","ind":"0.13"},{"date":"2025.09.09","stock":"-1.36","trade":"-2.41","ind":"-0.51"},{"date":"2025.09.08","stock":"2.84","trade":"1.77","ind":"0.38"},{"date":"2025.09.05","stock":"2.90","trade":"2.36","ind":"1.24"},{"date":"2025.09.04","stock":"-0.64","trade":"-1.63","ind":"-1.25"},{"date":"2025.09.03","stock":"-2.34","trade":"-0.22","ind":"-1.16"},{"date":"2025.09.02","stock":"-1.88","trade":"-2.00","ind":"-0.45"}]
通策医疗,上证指数,医疗服务指数
压力支撑
该股压力位为44.15元，支撑位为43.93元。
[{"text":"\u538b\u529b\u4f4d","value":"44.15","date":1759161600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"43.93","date":1759161600,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了15%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：10月02日 20:37
| 机构今日流向(万元) | 4316.43 | 机构5日流向(万元) | 2182.98 |
| 机构10日流向(万元) | -20982.52 | 机构20日流向(万元) | -27950.79 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1501.62万股，其中基金净减仓39家，主力净增仓5家，暂未发现中长期投资价值。
截止2025-06-30，共259家主力机构（基金256家，一般法人3家），持仓量总计22183.4万股，占流通A股49.60%
其中，基金持仓与2024-12-31相比：
增仓：48家 ，增持 489.68万股
减仓：87家 ，减持 1280.20万股
新出现在主力名单中：105家 ，持有244.83万股
从主力名单中消失：100家 ，原持有930.56万股
其中，基金持仓与2024-12-31相比：
增仓：48家 ，增持 489.68万股
减仓：87家 ，减持 1280.20万股
新出现在主力名单中：105家 ，持有244.83万股
从主力名单中消失：100家 ，原持有930.56万股
消息面诊股
诊断结果：5.6消息面打败了59%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 通策医疗：9月29日持仓该股ETF资金净流入178
2025-09-30 - 通策医疗：9月29日获融资买入4300.99万元
2025-09-30 - 通策医疗：目前，公司业绩正呈现稳步复苏态势，202
2025-09-29 - 通策医疗：9月26日持仓该股ETF资金净流出41.
2025-09-29 - 通策医疗：9月26日获融资买入3274.78万元
2025-09-27 - 行业周报|医疗服务指数跌-3.73%, 跑输上证指
2025-09-26 - 通策医疗：9月25日持仓该股ETF资金净流出164
2025-09-26 - 通策医疗：9月25日获融资买入4048.08万元
2025-09-26 - 通策医疗：9月24日获融资买入3231.51万元
2025-09-25 - 通策医疗：9月23日持仓该股ETF资金净流出32.
2025-09-24
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-06 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-12 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-17 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-10 |
| 利好 | 分红转增 | 10派4.5元(含税) | 2025-04-26 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-01 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.0行业面打败了69%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2025.09.30","price":"0.52","value":"1.51"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-2.13"},{"date":"2025.09.25","price":"-0.01","value":"0.08"},{"date":"2025.09.24","price":"0.83","value":"1.51"},{"date":"2025.09.23","price":"-0.18","value":"-3.08"},{"date":"2025.09.22","price":"0.22","value":"-0.10"},{"date":"2025.09.19","price":"-0.30","value":"-1.53"},{"date":"2025.09.18","price":"-1.15","value":"-1.87"},{"date":"2025.09.17","price":"0.37","value":"-0.79"},{"date":"2025.09.16","price":"0.04","value":"1.18"},{"date":"2025.09.15","price":"-0.26","value":"1.00"},{"date":"2025.09.12","price":"-0.12","value":"1.42"},{"date":"2025.09.11","price":"1.65","value":"-0.05"},{"date":"2025.09.10","price":"0.13","value":"1.48"},{"date":"2025.09.09","price":"-0.51","value":"-2.41"},{"date":"2025.09.08","price":"0.38","value":"1.77"},{"date":"2025.09.05","price":"1.24","value":"2.36"},{"date":"2025.09.04","price":"-1.25","value":"-1.63"},{"date":"2025.09.03","price":"-1.16","value":"-0.22"},{"date":"2025.09.02","price":"-0.45","value":"-2.00"}]
上证指数,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 创新医疗 | 70.84% | 5.33% | 5.2分 |
| 2 | 奥浦迈 | 22.28% | 11.90% | 6.4分 |
| 3 | 皓元医药 | 22.03% | 8.21% | 6.8分 |
| 4 | 益诺思 | 16.58% | -3.42% | 6.1分 |
| 5 | 毕得医药 | 13.76% | 8.97% | 5.7分 |
| 6 | 康龙化成 | 13.03% | 4.93% | 6.2分 |
| 8 | 昭衍新药 | 9.29% | -3.37% | 5.1分 |
| 10 | 九洲药业 | 4.35% | 7.76% | 5.7分 |
| 12 | ST中珠 | 3.78% | 0.00% | 4.6分 |
| 14 | 博腾股份 | 3.58% | 3.16% | 5.3分 |
| 16 | 诺禾致源 | 2.99% | 5.74% | 5.7分 |
| 18 | 新里程 | 2.28% | 0.90% | 5.0分 |
| 20 | 百花医药 | 0.21% | 3.15% | 6.2分 |
| 22 | 盈康生命 | -0.44% | 2.79% | 5.6分 |
| 24 | 成都先导 | -2.57% | 3.05% | 5.5分 |
| 26 | 万邦医药 | -3.71% | 0.80% | 4.9分 |
| 28 | 百诚医药 | -3.86% | -5.73% | 5.0分 |
| 30 | 澳洋健康 | -5.14% | -1.46% | 5.2分 |
| 32 | 兰卫医学 | -5.29% | 1.42% | 5.1分 |
| 34 | 迪安诊断 | -5.32% | 4.87% | 5.6分 |
| 36 | 华大基因 | -5.39% | 0.49% | 4.8分 |
| 38 | 药石科技 | -6.27% | 2.07% | 5.0分 |
| 40 | 金凯生科 | -6.63% | 3.11% | 5.0分 |
| 42 | 泓博医药 | -7.22% | 0.90% | 5.3分 |
| 44 | 南模生物 | -9.47% | -4.69% | 5.4分 |
| 46 | 睿智医药 | -11.82% | -4.52% | 4.6分 |
| 48 | 泰格医药 | -12.45% | 0.35% | 5.5分 |
| 50 | 皓宸医疗 | -27.77% | -7.25% | 4.7分 |
| 52 | 光正眼科 | - | 5.43% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/102 ， 22/102。
[{"date":"2025-06-30","value":"7.85","vol":"2.23"},{"date":"2025-03-31","value":"4.47","vol":"0.92"},{"date":"2024-12-31","value":"12.80","vol":"-0.15"},{"date":"2024-09-30","value":"12.56","vol":"3.24"},{"date":"2024-06-30","value":"8.00","vol":"2.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.85 | 4.47 | 12.80 | 12.56 | 8.00 |
| 行业(%) | 2.23 | 0.92 | -0.15 | 3.24 | 2.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"40.75","vol":"36.06"},{"date":"2025-03-31","value":"44.21","vol":"34.67"},{"date":"2024-12-31","value":"38.50","vol":"34.77"},{"date":"2024-09-30","value":"41.82","vol":"36.16"},{"date":"2024-06-30","value":"40.83","vol":"36.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
40.75 | 44.21 | 38.50 | 41.82 | 40.83 |
| 行业(%) | 36.06 | 34.67 | 34.77 | 36.16 | 36.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 29/102 ， 28/102。
[{"date":"2025-06-30","value":"2.68","vol":"2.42"},{"date":"2025-03-31","value":"5.11","vol":"-0.08"},{"date":"2024-12-31","value":"0.96","vol":"-0.73"},{"date":"2024-09-30","value":"2.21","vol":"0.87"},{"date":"2024-06-30","value":"3.52","vol":"0.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
2.68 | 5.11 | 0.96 | 2.21 | 3.52 |
| 行业(%) | 2.42 | -0.08 | -0.73 | 0.87 | 0.65 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.67","vol":"-71.46"},{"date":"2025-03-31","value":"6.22","vol":"-25.93"},{"date":"2024-12-31","value":"0.20","vol":"-96.53"},{"date":"2024-09-30","value":"-2.63","vol":"-161.08"},{"date":"2024-06-30","value":"1.77","vol":"-107.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
3.67 | 6.22 | 0.20 | -2.63 | 1.77 |
| 行业(%) | -71.46 | -25.93 | -96.53 | -161.08 | -107.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/102 ， 4/102。
[{"date":"2025-06-30","value":"0.23","vol":"0.20"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.47","vol":"0.41"},{"date":"2024-09-30","value":"0.37","vol":"0.31"},{"date":"2024-06-30","value":"0.23","vol":"0.20"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.23 | 0.12 | 0.47 | 0.37 | 0.23 |
| 行业(次) | 0.20 | 0.10 | 0.41 | 0.31 | 0.20 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"28.10","vol":"7.41"},{"date":"2025-03-31","value":"14.17","vol":"3.76"},{"date":"2024-12-31","value":"64.51","vol":"16.35"},{"date":"2024-09-30","value":"53.77","vol":"14.25"},{"date":"2024-06-30","value":"33.36","vol":"8.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
28.10 | 14.17 | 64.51 | 53.77 | 33.36 |
| 行业(次) | 7.41 | 3.76 | 16.35 | 14.25 | 8.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 10/102 ， 37/102。
[{"date":"2025-06-30","value":"29.57","vol":"15.87"},{"date":"2025-03-31","value":"19.84","vol":"-1.69"},{"date":"2024-12-31","value":"18.21","vol":"22.34"},{"date":"2024-09-30","value":"39.23","vol":"12.23"},{"date":"2024-06-30","value":"27.73","vol":"9.92"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 29.57 | 19.84 | 18.21 | 39.23 | 27.73 |
| 行业 | 15.87 | -1.69 | 22.34 | 12.23 | 9.92 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.11","vol":"0.94"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.24","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.44","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.11 | - | 1.24 | - | 1.44 |
| 行业 | 0.94 | 0.00 | 1.31 | 0.00 | 1.44 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/102 ， 3/102。
[{"date":"2025-06-30","value":"1.28","vol":"3.69"},{"date":"2025-03-31","value":"1.61","vol":"3.84"},{"date":"2024-12-31","value":"1.68","vol":"3.70"},{"date":"2024-09-30","value":"1.85","vol":"4.11"},{"date":"2024-06-30","value":"1.42","vol":"4.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.28 | 1.61 | 1.68 | 1.85 | 1.42 |
| 行业 | 3.69 | 3.84 | 3.70 | 4.11 | 4.14 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.15","vol":"2.98"},{"date":"2025-03-31","value":"1.48","vol":"3.12"},{"date":"2024-12-31","value":"1.55","vol":"3.01"},{"date":"2024-09-30","value":"1.72","vol":"3.38"},{"date":"2024-06-30","value":"1.32","vol":"3.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.15 | 1.48 | 1.55 | 1.72 | 1.32 |
| 行业 | 2.98 | 3.12 | 3.01 | 3.38 | 3.39 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/102 ， 26/102。
[{"date":"2025-06-30","value":"27.51","vol":"32.65"},{"date":"2025-03-31","value":"26.97","vol":"32.24"},{"date":"2024-12-31","value":"29.49","vol":"32.31"},{"date":"2024-09-30","value":"27.74","vol":"31.03"},{"date":"2024-06-30","value":"30.70","vol":"31.65"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
27.51 | 26.97 | 29.49 | 27.74 | 30.70 |
| 行业(%) | 32.65 | 32.24 | 32.31 | 31.03 | 31.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.41","vol":"0.95"},{"date":"2025-03-31","value":"0.40","vol":"0.98"},{"date":"2024-12-31","value":"0.45","vol":"1.01"},{"date":"2024-09-30","value":"0.42","vol":"0.85"},{"date":"2024-06-30","value":"0.48","vol":"0.87"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.41 | 0.40 | 0.45 | 0.42 | 0.48 |
| 行业(%) | 0.95 | 0.98 | 1.01 | 0.85 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国泰海通证券 | 2025-09-09 | 买入 | |
| 华泰金融(HK) | 2025-09-09 | 买入 | |
| 开源证券 | 2025-08-28 | 买入 | |
| 平安证券 | 2025-08-26 | 增持 | |
| 广发证券 | 2025-08-25 | 买入 | |
| 国金证券 | 2025-08-24 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.48","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.01","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.40","blueLineValue":"1.21","type":"YC"}]